Loading…
Oaktree Acquisition Corp. III Life Sciences
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in OACCU.
▲ +10.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Financial Services, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| AFJKAimei Health Technology Co., Ltd. | $12.10 | 172.9x | — | — | — | $38.31M |
| AEAQActivate Energy Acquisition Corp. | $10.10 | — | — | — | — | $316.25M |
| AESPAeon Acquisition I Corp. | $9.98 | — | — | — | — | $213.35M |
| APMCAmperCap Acquisition Co | $9.98 |
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Company description provided by Yahoo Finance.
| — |
| 255.9x |
| — |
| — |
| $199.19M |
| AXINAxiom Intelligence Acquisition Corp 1 | $10.33 | — | — | — | — | $350.53M |
| ABTCAmerican Bitcoin Corp. | $8.84 | — | 1.0x | — | -38.53% | $1.08B |